Fujimoto et al.6revealed that NSCLC patients with increased PD‐L1 expression after preoperative chemoradiotherapy showed a significantly worse OS than those with unchanged or decreased PD‐L1 expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.